English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduAlthough respiratory symptoms are the main clinical manifestations of SARS-CoV-2 infection, a neurological involvement is clearly present. Anosmia (loss of smell), ageusia (loss of taste), cough, fatigue and headache are reported as the most common mild neurological symptoms, while some patients can experience severe ones, such as encephalopathy and acute cerebrovascular diseases.
The researchers include SHRO Director and Founder Antonio Giordano, M.D., Ph.D., with collaborators at Temple University, and the University of Siena, Italy.
Variability of COVID-19 clinical manifestations could be explained by the ubiquitous expression of the human cell receptors to which the viral protein Spike1 can interact. Such receptors are present not only in the lower respiratory tract, but also in extrapulmonary sites such as heart, kidney, endothelial cells of blood vessels, and the nervous system.
These observations have sparked interest in the ability of the virus to interact with different tissues and damage them directly or indirectly through the inflammatory response.
The authors conclude that neurologic symptoms are one of the clinical aspects of SARS-CoV-2 infection and are prevalently associated with conditions in which the immune system is diminished, as in elderly patients and severe clinical profiles. These neurological manifestations are associated with more severe disease, leading to a longer recovery, and higher death rates during hospitalization.
About the Sbarro Health Research Organization
The Sbarro Health Research Organization (SHRO) is non-profit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses and to foster the training of young doctors in a spirit of professionalism and humanism. To learn more about the SHRO please visit www.shro.org
